# EYonro

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/eyonro

- Industry: Medical Devices & Equipment
- Headquarters: Wuxi, China
- Latest round: Angel (Oct 13, 2025)
- Investors on record: 1

## About

Founded in 2023 and based in Wuxi, China, EYonro focuses on innovative non-invasive neuromodulation technologies. In April 2025, its self-developed EYonro wearable low-frequency therapeutic device obtained official medical device registration approval, becoming the first domestically approved non-invasive wearable device in China to target the thalamic central nervous motion circuit via peripheral nerve stimulation. EYonro’s core product, the EYonro wearable low-frequency therapeutic device, integrates precision nerve stimulation technology with ergonomic wearable design. It is designed for the treatment of movement disorders such as essential tremor (ET) and Parkinson’s disease (PD)-related upper limb tremors. The company’s R&D efforts focus on enhancing neuromodulation accuracy, improving treatment comfort, and broadening clinical indications through AI-assisted signal processing and personalized stimulation algorithms. The company generates revenue from the sale of its proprietary wearable neuromodulation medical devices, clinical partnerships, and future licensing of its non-invasive neural stimulation technology for therapeutic and research applications.
In October 2025, EYonro closed Angel funding from new investor Vertex Ventures China.

## Funding rounds

- Angel, Oct 13, 2025 — Vertex Ventures China

## Investors

- Vertex Ventures China (https://capitalatlas.ai/funds/vertex-ventures-china) — Angel